Apr 28, 2020   SOURCE: PR NewsWire

Global Neuropathic Pain Clinical Trial Pipeline: What Products Are Due to be Launched?

DUBLIN, April 28, 2020 /PRNewswire/ -- The "Global Neuropathic Pain Clinical Trial Pipeline Highlights - 2020" report has been added to ResearchAndMarkets.com's offering.

http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

The report Neuropathic Pain Pipeline Highlights - 2020, provides the most up-to-date information on key pipeline products in the global Neuropathic Pain market. It covers emerging therapies for Neuropathic Pain in active clinical development stages including early and late-stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:
The report provides Neuropathic Pain pipeline products by clinical trial stages including both early and late-stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:
The report provides Neuropathic Pain pipeline products by their dominant mechanism of action/drug class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:
The report provides Neuropathic Pain pipeline products by company.

Short-term Launch Highlights:
Find out which Neuropathic Pain pipeline products will be launched in the US and beyond to 2025.

Key Topics Covered:

1. Neuropathic Pain Pipeline by Stages
2. Neuropathic Pain Phase 3 Clinical Trial Insights
3. Neuropathic Pain Phase 2 Clinical Trial Insights
4. Neuropathic Pain Phase 1 Clinical Trial Insights
5. Neuropathic Pain Preclinical Research Insights
6. Neuropathic Pain Discovery Stage Insights
7. Appendix
8. Research Methodology

List of Tables
Table 1: Neuropathic Pain Phase 3 Clinical Trials, 2020
Table 2: Neuropathic Pain Phase 2 Clinical Trials, 2020
Table 3: Neuropathic Pain Phase 1 Clinical Trials, 2020
Table 4: Neuropathic Pain Preclinical Research, 2020
Table 5: Neuropathic Pain Discovery Stage, 2020

List of Figures
Figure 1: Neuropathic Pain Pipeline Molecules by Clinical Trials Stage, 2020
Figure 2: Neuropathic Pain Phase 3 Clinical Trial Highlights, 2020
Figure 3: Neuropathic Pain Phase 2 Clinical Trial Highlights, 2020
Figure 4: Neuropathic Pain Phase 1 Clinical Trial Highlights, 2020
Figure 5: Neuropathic Pain Preclinical Research Highlights, 2020
Figure 6: Neuropathic Pain Discovery Stage Highlights, 2020

For more information about this report visit https://www.researchandmarkets.com/r/h1toaa

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-neuropathic-pain-clinical-trial-pipeline-what-products-are-due-to-be-launched-301048372.html

SOURCE Research and Markets